Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,769,081
+$641,121 QoQ
Shares Held
18,952
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#1,342
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. ABBV ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,769,081 | 18,952 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,127,960 | 18,980 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,235,747 | 18,538 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,148,502 | 17,917 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,239,440 | 17,452 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,451,213 | 16,472 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,890,823 | 16,268 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,202,928 | 16,219 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,761,643 | 16,101 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,901,217 | 15,932 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,440,467 | 15,748 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,420,287 | 16,237 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,173,329 | 16,131 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,512,627 | 15,766 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $2,454,855 | 15,190 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,037,442 | 15,181 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,278,867 | 14,879 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,278,998 | 20,227 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,152,653 | 23,284 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,404,314 | 22,289 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,713,704 | 15,214 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,559,883 | 14,414 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,470,633 | 13,725 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,067,984 | 12,193 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,147,135 | 11,684 | Shares | Sole | 2020-08-04 | |
| No filing history on record for this holder in this stock. | ||||||